Article
Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention.
Pharmacogenomics - 1 Sept 2011
Rideg Orsolya, Komócsi András, Magyarlaki Tamás, Tokés-Füzesi Margit, Miseta Attila, Kovács Gábor L, Aradi Dániel
Abstract excerpt
AIM: To determine the effect of various SNPs on post-clopidogrel platelet reactivity and clinical outcome. MATERIALS & METHODS: Cytochrome 2C19 (CYP2C19) loss-of-function (LOF; *2, *3) and gain-of-function (GOF; *17) allelic variants, together with ABCB1 (3435 C→T and 2677 G→T/A) and paraoxonase-1 (PON-1; 192 Q→R) SNPs were analyzed in 189 patients after elective stent implantation who participated in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
